FdaApplication
ANDA 209010
Identifiers
- fda_app_no: ANDA209010
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2018-12-03 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 10MG BASE;20MG | TABLET;ORAL |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 5MG BASE;40MG | TABLET;ORAL |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 5MG BASE;20MG | TABLET;ORAL |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL | EQ 10MG BASE;40MG | TABLET;ORAL |
4 products